Genetic analysis of stem cell maintenance in vivo
体内干细胞维持的遗传分析
基本信息
- 批准号:7921521
- 负责人:
- 金额:$ 37.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-24 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AllelesAngiopoietin-1BindingBlood CellsBlood VesselsBone MarrowBreedingCXCL12 geneCell CycleCell LineageCell MaintenanceCell physiologyCellsDataDefectEndosteal CellEndothelial CellsGrowth FactorHematopoiesisHematopoietic stem cellsInjuryLifeMaintenanceMegakaryocytesMembraneMusOsteoblastsPartner in relationshipPericytesPhysiologicalRegulationSourceStem Cell FactorStem cellsSupporting CellSurfaceTestingTissuescell motilitycell typedesigngenetic analysisin vivopromoterpublic health relevancerecombinaseresearch studyself-renewalstem cell niche
项目摘要
DESCRIPTION (provided by applicant): Hematopoietic stem cells (HSCs) persist throughout life and dynamically regulate their numbers after injury by undergoing self-renewing divisions that depend upon both cell- intrinsic and cell-extrinsic mechanisms. With respect to cell-extrinsic mechanisms, HSCs are thought to reside within specialized microenvironments created by supporting cells in the bone marrow that express membrane-bound and secreted factors that promote HSC maintenance (survival and self-renewal), and that regulate HSC migration, quiescence, and differentiation. Many bone marrow HSCs reside at, or near, the osteoblasts at the endosteal surface and osteoblasts have been proposed to secrete a number of factors that promote HSC maintenance. Many HSCs also reside adjacent to sinusoidal blood vessels in the bone marrow, and vascular or perivascular cells have also been proposed to secrete factors that regulate HSC maintenance. Nonetheless, none of these factors have ever been conditionally deleted from any candidate niche cell. As a result, the physiological sources of these factors have never been tested in functional experiments. Angiopoietin-1 (Ang-1), Stem Cell Factor (SCF), and CXCL12 are all genetically required for maintenance of normal numbers of HSCs but none of these factors have been conditionally deleted from osteoblasts or from vascular/perivascular cells to identify the biologically important source(s) of these factors. Ultimately, it will not be possible to identify the cells that create HSC niches without genetically identifying the cells that secrete factors required for HSC maintenance. Our preliminary expression data suggest that megakaryocytes are the major source of Ang-1 in the bone marrow and that there are multiple sources of SCF including both endothelial cells and endosteal cells. To test which cells are functionally important sources of these factors for HSC maintenance we have generated floxed alleles of Ang-1 and Scf and propose to mate mice bearing these alleles with mice expressing Cre-recombinase under the control of promoters specific to osteoblasts, megakaryocytes, and endothelial cells. These experiments will also test whether a single cell type is the main source of multiple factors required for HSC maintenance or whether different cell types produce different factors that regulate HSCs. This will provide the first functional test of which cells regulate HSC maintenance in vivo.
PUBLIC HEALTH RELEVANCE: This project is designed to assess which cells are the physiologically important sources of growth factors that are critical for the maintenance and regulation of hematopoietic stem cells. This will provide important new information regarding the identities of the cells that constitute the hematopoietic stem cell niche in vivo. Such information is critical to understand how blood cell formation is regulated and how stem cells are sustained in this tissue throughout life.
描述(由申请人提供):造血干细胞(HSC)在整个生命过程中持续存在,并通过依赖于细胞内在和细胞外在机制的自我更新分裂在损伤后动态调节其数量。关于细胞外源性机制,HSC被认为存在于由骨髓中的支持细胞产生的特殊微环境中,所述骨髓中的支持细胞表达促进HSC维持(存活和自我更新)的膜结合和分泌因子,并且调节HSC迁移、静止和分化。许多骨髓HSC位于或靠近骨内膜表面的成骨细胞,并且已提出成骨细胞分泌许多促进HSC维持的因子。许多HSC也存在于骨髓中的窦状血管附近,并且血管或血管周围细胞也被提出分泌调节HSC维持的因子。尽管如此,这些因素中没有一个曾经被有条件地从任何候选生态位细胞中删除。因此,这些因素的生理来源从未在功能实验中进行过测试。血管生成素-1(Ang-1)、干细胞因子(SCF)和CXCL 12都是维持正常数量的HSC在遗传上所需的,但这些因子都没有从成骨细胞或血管/血管周细胞中有条件地删除,以确定这些因子的生物学重要来源。最终,如果不从遗传学上鉴定出分泌HSC维持所需因子的细胞,就不可能鉴定出产生HSC小生境的细胞。我们的初步表达数据表明,巨核细胞是骨髓中Ang-1的主要来源,SCF有多种来源,包括内皮细胞和骨内膜细胞。为了测试哪些细胞是HSC维持的这些因子的功能重要来源,我们产生了Ang-1和Scf的floxed等位基因,并建议将携带这些等位基因的小鼠与在成骨细胞、巨核细胞和内皮细胞特异性启动子控制下表达Cre重组酶的小鼠交配。这些实验还将测试单个细胞类型是否是HSC维持所需的多种因子的主要来源,或者不同的细胞类型是否产生调节HSC的不同因子。这将提供第一个功能测试的细胞调节HSC的维持在体内。
公共卫生相关性:该项目旨在评估哪些细胞是对造血干细胞的维持和调节至关重要的生长因子的生理重要来源。这将提供重要的新的信息,关于构成造血干细胞龛在体内的细胞的身份。这些信息对于了解血细胞形成是如何调节的以及干细胞如何在整个生命过程中维持在这个组织中至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEAN J MORRISON其他文献
SEAN J MORRISON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEAN J MORRISON', 18)}}的其他基金
Cancer Biology Research Test-Bed Unit 2: Effects of cell-intrinsic and cell-extrinsic variations in lipid metabolism on metastasis patterns
癌症生物学研究试验台单元 2:脂质代谢的细胞内在和细胞外在变化对转移模式的影响
- 批准号:
10374653 - 财政年份:2021
- 资助金额:
$ 37.26万 - 项目类别:
Cancer Biology Research Test-Bed Unit 2: Effects of cell-intrinsic and cell-extrinsic variations in lipid metabolism on metastasis patterns
癌症生物学研究试验台单元 2:脂质代谢的细胞内在和细胞外在变化对转移模式的影响
- 批准号:
10491356 - 财政年份:2021
- 资助金额:
$ 37.26万 - 项目类别:
Cancer Biology Research Test-Bed Unit 2: Effects of cell-intrinsic and cell-extrinsic variations in lipid metabolism on metastasis patterns
癌症生物学研究试验台单元 2:脂质代谢的细胞内在和细胞外在变化对转移模式的影响
- 批准号:
10684866 - 财政年份:2021
- 资助金额:
$ 37.26万 - 项目类别:
The Metabolic Regulation of Hematopoietic Stem Cell Function
造血干细胞功能的代谢调节
- 批准号:
10560625 - 财政年份:2019
- 资助金额:
$ 37.26万 - 项目类别:
The Metabolic Regulation of Hematopoietic Stem Cell Function
造血干细胞功能的代谢调节
- 批准号:
10343751 - 财政年份:2019
- 资助金额:
$ 37.26万 - 项目类别:
The Metabolic Regulation of Hematopoietic Stem Cell Function
造血干细胞功能的代谢调节
- 批准号:
9914262 - 财政年份:2019
- 资助金额:
$ 37.26万 - 项目类别:
The regulation of protein synthesis in stem cells
干细胞中蛋白质合成的调控
- 批准号:
8997792 - 财政年份:2015
- 资助金额:
$ 37.26万 - 项目类别:
相似国自然基金
Angiopoietin-1通过激活YAP重启心肌梗死后心肌细胞增殖的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于Angiopoietin-1/Tie2信号轴的骨髓间充质干细胞抑制腹主动脉瘤巨噬细胞浸润机制研究
- 批准号:81700409
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双基因活性真皮支架介导VEGF和Angiopoietin-1共表达及序贯性调控血管化进程的研究
- 批准号:81772069
- 批准年份:2017
- 资助金额:52.0 万元
- 项目类别:面上项目
Reg3α促进Angiopoietin-1介导的胰腺癌新生血管形成及侵袭转移分子机制研究
- 批准号:81502089
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
Angiopoietin-1和L-mimosine改善糖尿病肾脏微血管异常及机制研究
- 批准号:81260118
- 批准年份:2012
- 资助金额:49.0 万元
- 项目类别:地区科学基金项目
通心络联合Angiopoietin-1基因修饰改善MSCs移植微环境及心肌梗死后心肌重构的作用和机制
- 批准号:81202830
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
Angiopoietin-1在2型糖尿病中对胰岛细胞量的保护作用
- 批准号:81070656
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
Angiopoietin-1促进神经发生及其机制的研究
- 批准号:30600167
- 批准年份:2006
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Angiopoietin-1 might be a novel therapeutic strategy for injured pulmonary capillaries in the developing lung
Angiopoietin-1可能是一种治疗发育中肺部受损肺毛细血管的新策略
- 批准号:
16K10111 - 财政年份:2016
- 资助金额:
$ 37.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Association of angiopoietin-1 genetic polymorphisms with altered clinical outcome in septic shock
血管生成素-1 基因多态性与感染性休克临床结果改变的关联
- 批准号:
25670758 - 财政年份:2013
- 资助金额:
$ 37.26万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Vasoprotective protein Angiopoietin-1 is a novel therpeutic target molecule for cerebral ischemia
血管保护蛋白Angiopoietin-1是脑缺血的新型治疗靶分子
- 批准号:
25430063 - 财政年份:2013
- 资助金额:
$ 37.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Angiopoietin-1-mediated vascular development and maturation in the developing heart
发育中心脏中血管生成素 1 介导的血管发育和成熟
- 批准号:
25293183 - 财政年份:2013
- 资助金额:
$ 37.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The role of angiopoietin-1 in the self-renewal and metastasis of prostate cancer stem cells
血管生成素-1在前列腺癌干细胞自我更新和转移中的作用
- 批准号:
nhmrc : 1031221 - 财政年份:2012
- 资助金额:
$ 37.26万 - 项目类别:
Project Grants
Regulation of the expression balance of angiopoietin-1 and angiopoietin-2 by Shh and FGF-2: The role of Shh in angiogenesis.
Shh 和 FGF-2 对 angiopoietin-1 和 angiopoietin-2 表达平衡的调节:Shh 在血管生成中的作用。
- 批准号:
23591890 - 财政年份:2011
- 资助金额:
$ 37.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vascular stabilization and destabilization by angiopoietin-1/Tie2 system
血管生成素-1/Tie2 系统的血管稳定和不稳定
- 批准号:
22390040 - 财政年份:2010
- 资助金额:
$ 37.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Scaffolds covalently immobilized with VEGF and angiopoietin-1 to promote angiogenesis in engineered cardiac tissues
共价固定 VEGF 和血管生成素-1 的支架可促进工程心脏组织中的血管生成
- 批准号:
346998-2009 - 财政年份:2010
- 资助金额:
$ 37.26万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Angiopoietin-1 mimetics: new therapeutic agents for cancer treatment.
血管生成素-1 模拟物:癌症治疗的新治疗剂。
- 批准号:
217998 - 财政年份:2010
- 资助金额:
$ 37.26万 - 项目类别:
Studentship Programs
Angiopoietin-1 mimetics: new therapeutic agents for cancer treatment.
血管生成素-1 模拟物:癌症治疗的新治疗剂。
- 批准号:
229517 - 财政年份:2010
- 资助金额:
$ 37.26万 - 项目类别:
Studentship Programs